Brendon Neuen's Publications

About Brendon Neuen's Publications

Program Lead, Renal and Metabolic
  • Nephrologist and Director, Kidney Trials, Royal North Shore Hospital
  • Clinical Associate Professor, University of Sydney
  • Conjoint Associate Professor, UNSW Sydney
  • Ph.D. ,
  • MBBS(Hons),
  • MSc(Oxon),
  • FRACP,
  • FASN

  • Effects of Aldosterone Synthase Inhibitor Baxdrostat on Albuminuria in CKD and Uncontrolled Hypertension

    Clinical Journal of the American Society of Nephrology Date published:

  • Novel Protein Biomarkers to Monitor Kidney Function Decline and Treatment Response in Individuals With Normoalbuminuria and Type 2 Diabetes

    Diabetes Date published:

  • High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study

    Nephrology Dialysis Transplantation Date published:

  • Lipid-Lowering Therapy in Individuals with CKD

    Clinical Journal of the American Society of Nephrology Date published:

  • The challenge of introducing aldosterone synthase inhibitors into multidisciplinary practice

    American Journal of Hypertension Date published:

  • Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement

    European Journal of Heart Failure Date published:

  • Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

    Nature Reviews Nephrology Date published:

  • Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial

    Nephrology Dialysis Transplantation Date published:

  • ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome

    Journal of the American Society of Nephrology Date published:

  • An individual patient meta-analysis assessed the associations between change in albuminuria and acute changes in the glomerular filtration rate in randomized controlled trials of chronic kidney disease progression

    Kidney International Date published:

  • Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

    European Heart Journal Date published:

  • Does Intravenous Iron Improve Survival and Physical Function and Reduce Heart Failure Events in Patients with Chronic Kidney Disease?

    NEJM Evidence Date published:

  • Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

    Diabetes, Obesity and Metabolism Date published:

  • Cardiovascular Risk Prediction with the Kidney Failure Risk Equation in the Chronic Renal Insufficiency Study

    Kidney360 Date published:

  • Cardiologists as Champions of Kidney Health in the CKM Era

    JACC Date published:

  • Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025

    British Journal of Clinical Pharmacology Date published: